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Introduction
Rabies is an acute, viral, encephalitic disease unique to
mammals (Niezgoda et al., 2002). Following the onset of
symptoms, its neurological effects are usually fatal. In
North America, wildlife (e.g. raccoons, bats, skunks,
foxes) serves as the main reservoir for the disease, includ-
ing multiple variants where virus transmission is primar-
ily between members of the same species (Blanton et al.,
2009). The spread of rabies can have serious impacts to
animal and human health, as well as significant costs to
the human health system, particularly when exposure
occurs in densely populated areas. Rabies prevention is a
model for ‘One Health’ medicine in that wildlife manag-
ers, veterinarians and medical doctors collaborate to suc-
cessfully provide rabies vaccination to wildlife,
companion animals, livestock and humans, as well as
public education. This unique collaboration among a
myriad of public health professionals provides a blueprint
for the eventual successful elimination of a zoonotic dis-
ease (Shwiff et al., 2008).
Currently, the raccoon rabies virus variant (hereafter
raccoon rabies) is enzootic in much of the Eastern United
States, and prevention of its northward spread is of con-
cern in Ontario and Quebec provinces, Canada, (Mac-
Innes et al., 2001; Blanton et al., 2009). A variety of
methods are used to manage raccoon rabies at the land-
scape and population level including: oral rabies vaccina-
tion (ORV), trap-vaccinate-release and population
reduction. In an economic sense, all of these methods are
designed to reduce the monetary damage caused by the
presence of the disease and the potential to infect
humans, livestock, companion animals and other wildlife
species.
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Summary
Beginning in 2006, point infection control operations and aerial distribution of
oral rabies vaccines along the US border were performed in Quebec, Canada,
to control the potential spread of raccoon rabies. A benefit-cost analysis
assessed the economic efficiency of this rabies control programme into the
future. In this study, a mathematical simulation model was used to determine
the potential spread of raccoon rabies from the 2006 index case, and incidence
rates of human post-exposure prophylaxis (PEP), animal testing and human
exposure investigations were calculated. Benefits were calculated as the poten-
tial savings from reduced numbers of human PEP, animal testing and human
exposure investigations owing to control, which ranged from $47 million to
$53 million. Programme cost scenarios were based on projections of total
expenditures, which ranged from $33 million to $49 million. Economic effi-
ciency was indicated for approximately half of the modelled scenarios, with the
greatest benefit-cost ratios resulting from reduced future programme costs.
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The major economic impacts of raccoon rabies are
derived from human post-exposure prophylaxis (PEP),
animal rabies tests (AT), human exposure investigations
(INVT), livestock deaths, pet vaccinations and public
education efforts (Meltzer and Rupprecht, 1998a,b; Ster-
ner and Sun, 2004). Recent economic assessments have
shown that these economic impacts spike during rabies
epizootics, and have attempted to quantify both rabies-
and ORV-incurred costs (Uhaa et al., 1992; Kreindel
et al., 1998; Chang et al., 2002; Foroutan et al., 2002;
Nunan et al., 2002; Shwiff et al., 2007, 2009, 2011). Addi-
tional economic analyses have evaluated ORV programmes
using benefit-cost analysis (BCA), with increased PEP, AT
and pet vaccinations as the principle driver of cost (Melt-
zer, 1996; Kemere et al., 2002; Shwiff et al., 2008).
Raccoon rabies was first detected in southern Quebec
along the US (Vermont) border in 2006. Previously, the
province had been considered raccoon rabies free and it
is assumed that the disease was introduced via wildlife
movement across the international boundary. The num-
ber of detected raccoon rabies–positive animal cases
increased from four in 2006 to 66 in 2007 and 32 in
2008. Because of the close proximity of human and rac-
coon populations in Quebec, the wide range (including
urban) and density of raccoon populations and continued
priority given to raccoon rabies control within the United
States, the Quebec government initiated a raccoon rabies
control programme. Between 2006 and 2009, several mil-
lion rabies vaccines targeting raccoons were distributed by
air or ground over a 9500 square kilometre area of south-
ern Quebec province to control this outbreak. This rac-
coon rabies control programme slowed the spread of the
disease on the east side of the Richelieu River, 40 km
southeast of Montreal city. Only two new cases of rac-
coon rabies in skunks were detected in the southern part
of the infected area in 2009. Quebec effectively halted the
spread and reduced the size of the epizootic through the
province, thereby neutralizing the potential economic
impacts associated with the spread of the disease.
This study provides an innovative bioeconomic meth-
odology to estimate the benefits and costs associated with
the Quebec raccoon rabies control programme starting in
2006 and projected until 2018. To estimate the potential
benefits of the control programme, the methodology
combines a dynamic spatial disease spread model for the
simulation of the rabies epizootic among the raccoon
population and economic quantification of the associated
PEP, AT and INVT frequencies (Rees et al., 2009).
Materials and Methods
Benefit-cost analysis is a common tool used by econo-
mists to evaluate, among many others, government
programmes and to determine the efficiency of manage-
ment efforts. In a BCA, the monetary benefits and costs
of programme actions are identified and compared (Nas,
1996). Estimating the economic benefit of preventing the
spread of a previously undocumented variant of rabies
into the province of Quebec, and potentially the rest of
Canada, requires the quantification of non-marketed
goods and services. One accepted methodology to value
non-market services is the damage-avoided method,
which uses the value of resources protected as a measure
of the benefits provided by the raccoon rabies control
programme. Here, it was posited that the raccoon rabies
control programme slowed the movement of raccoon
rabies into the study area. The benefits of the control
programme were calculated as the savings from reducing
the number of PEP, AT and INVT necessary, plus the
associated costs that would potentially be borne by indi-
viduals as a result of human rabies exposure (e.g. expen-
ditures on over-the-counter medications, lost work time
and travel to receive treatment). These avoided costs
make up the majority of benefits derived from rabies
control programmes (Shwiff et al., 2008, 2009, 2011).
The raccoon rabies control programme began in 2006
and costs included salaries, vaccines, baits, aircraft opera-
tions, enhanced surveillance and public communication
costs. Actual costs were used from 2006 to 2009 and then
extrapolated into the future (up to 2018) based on 2009
levels, as this was the first year of full programme fund-
ing. Thus, for this study, total benefits and total costs of
the raccoon rabies control programme were estimated
from 2007 to 2018. The 12-year study period ending in
2018 used to evaluate the programme was based on prac-
tical considerations associated with government agencies
ability to project the scale and scope of rabies control
activities into the future.
Disease spread modelling
Because benefits are derived from the human population
at risk (HPR), the objective of the disease spread simula-
tion in a resident raccoon population was to calculate
HPR located in and close to the areas infected by rabid
raccoons. The model used was the Ontario Rabies Model
(ORM; Rees et al., 2009). The ORM has been validated
using genetic data (Rees, 2008; Rees et al., 2008a). Addi-
tional information on the ORM behaviour, including sen-
sitivity analysis, is provided in Rees et al. (2008b).
The ORM is an individual-based stochastic and
dynamic model using raccoons as simulated objects and
has the ability to model the dispersion of raccoon rabies
in a raccoon population through time and space. The
study region was 32 400 km2 and was located in southern
Quebec province, delineated to the south by the border
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with the United States, to the North by the Saint Law-
rence River and the southwest edge of the city of Quebec.
The first raccoon rabies case detected on 6 June 2006
by the passive public health surveillance system in Quebec
was used as the index case of two simulated epizootic sce-
narios; one with control and one without control mea-
sures, spanning from 2006 to 2018. The simulated rabies
control programmes were located in areas corresponding
to the actual vaccination area (2006–2008). The control
measures were only an approximation of the real control
measures undertaken. For example, population reduction
implemented in 2006 and 2007 was not taken into
account, and the size of the ORV zone was not adjusted
in relation to the geographic spread of raccoon rabies
overtime. Hence, these simulations should not be inter-
preted as an evaluation of the field control programme.
No cost reductions in the control programme were specif-
ically simulated; however, the economic analysis incorpo-
rated certain efficiency gains associated with future
projected baiting scenarios. Tinline, 2007 describes the
selection procedure for the representative dispersion area
to calculate the HPR, which was calculated using the
2006 population census data (Ludwig et al., 2009a).
The HPR calculation follows the criteria proposed by the
Institut national de sante´ publique du Que´bec (Lambert
et al., 2007). The front of the simulated epizootic without
control measures (baseline) reached the fringe of the
defined study area as soon as 2011, while the simulated
epizootics including control measures will not reach the
border of the study area in 2018. To extend the baseline
population at risk to 2018, the HPR for the epizootic
without control measure was extrapolated from 2012 to
2018 based on the 2011 level. Therefore, no population
increases or decreases are built into the model for the
future (2012–2018) period in the specific case without
control measures. Because raccoon rabies spreading North
meant that rabies would impact the urban area of Mon-
treal, it was realistic to assume this would be considered a
risk for many years into the future by the responsible
rabies management and public health agencies. The differ-
ence between the baseline HPR without control and the
estimated HPR with control was those individuals that
were not at risk of raccoon rabies exposure because of the
control programme (Fig. 1). This difference between the
two simulations represents the number of individuals
protected by the programme and was used to calculate
the benefits of the raccoon rabies control programme.
Derivation of benefits
The number of individuals protected or ‘saved’ by the
programme was then combined with the rates of inci-
dence of PEP, AT and INVT per 100 000 people to
monetize the benefits of the programme. To accomplish
this, the annual case frequency of PEP and AT during
raccoon rabies epizootics in the Eastern United States
and Eastern Canada was used as proxies (Shwiff et al.,
2008). Data regarding annual PEP and AT rates reported
in New Jersey (Uhaa et al., 1992), New York (Wyatt
et al., 1999) and New Brunswick (Department of Health,
New Brunswick Provincial Government 2008, unpub-
lished data) were used to determine the hypothetical case
frequency that could have existed in the absence of a
raccoon rabies control programme. New Jersey, New
York and New Brunswick raccoon rabies epizootic PEP
rates were reported as 66, 43.5 and 14; AT rates were
reported as 483, 65 and 45 per 100 000 people, respec-
tively. Determination of the number of INVT was
accomplished using data provided by the Direction de
sante´ publique de l’Agence de la sante´ et des services
sociaux de la Monte´re´gie. Data collected in Monte´re´gie,
Quebec, from 1995 to 2006 (excluding bat exposure)
indicate that for every PEP administered an average 8.71
(range, 4.07–20.17) INVT occurred. Therefore, in this
report, the number of INVT was directly estimated
based upon the PEP savings.
The annual total benefits equal PEP, AT and INVT
costs owing to raccoon rabies cases saved. The predicted
frequency level of PEPs per 100 000 saved was the average
number of PEPs per 100 000 minus the actual number
(the average number of PEPs from 1995 to 2006 reported
in the study area). PEPs previous to 2006 raccoon variant
rabies epizootic were the result of contact with different
species of animals (excluding bat exposures). This infor-
mation was combined with the costs associated with PEP
annually. Two different levels of PEP costs were used for
the analysis. For level 1, no indirect costs were included,
and for level 2, the cost of PEP was increased by 33% to
Fig. 1. Annual human population estimated to be at risk for rabies
exposure (2006–2018).
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include indirect costs associated with rabies exposure.
Shwiff et al. (2007) provides the most current and
detailed estimation of direct and indirect costs associated
with a rabid animal exposure. Direct costs refer to the
vaccine, other biological materials and the health profes-
sional salaries, while indirect costs refer to over-the-coun-
ter medicines, travel to physicians and lost time from
work associated with human rabies exposure. Indirect
costs composed approximately one-third (33%) of the
total costs associated with a rabid animal exposure. The
calculation of the cost savings related to AT was similar.
The predicted frequency level of AT was compared to the
actual number of ATs (the average number from 1995 to
2006 reported in the study area). This information was
combined with the human population saved and the costs
associated with AT, to calculate the cost savings during a
particular year. The number of INVT was derived from
the number of PEPs. This information was combined
with the costs associated with INVT, to calculate the cost
savings during a particular year.
The monetary savings per PEP, AT and INVT avoided
were determined given the calculated number of cases
prevented multiplied by the cost. The cost information
for PEP, AT and INVT was estimated at $1463.75 (rabies
vaccines: $860 for five doses, immunoglobulin: $516 for a
mean of 8 ml, salary of a nurse: $45/h, mean duration of
PEP administration: 1.5 h. Costs and duration were pro-
vided by the Ministe`re de la sante´ et des services sociaux
du Que´bec), $269 (sample collection: $172, sample ship-
ping: $5, travel: $40.60, laboratory processing: $30, quar-
antine of domestic animals: $20, indemnification
payment: $2.30$. Costs were provided by Canadian Food
Inspection Agency) and $124 (mean salary of a health
professional: $55/h, mean duration of an investigation:
2.25 h. Costs and duration were provided by the Minist-
e`re de la sante´ et des services sociaux du Que´bec) in 2008
Canadian dollars (CAD) per incident, respectively.
Estimation of these cost saving components permits
the determination of the total programme benefits. The
calculation of benefits was over the entire time period
since the initiation of the control programme. All esti-
mates of cost savings were calculated in 2008 dollars.
Therefore, the total benefits calculated represent the pres-
ent value of the entire raccoon rabies control programme
for each year, from 2006 to 2018. It should be noted that
not all benefits created by controlling raccoon rabies
could be captured in this analysis. For example, the sav-
ings associated with a reduction in companion animal
and livestock vaccinations along with any treatment (e.g.
emergency care, quarantine, medications) were not fac-
tored into the analysis because of data limitations. Omis-
sion of these benefits creates more conservative
programme benefit-cost ratios (Kemere et al., 2002).
Derivation of costs
Three control programme cost scenarios were developed
to model future costs (Table 1). Scenario 1 does not
include any future cost reductions; however, in Scenarios
2 and 3, the potential for future efficiency gains in the
raccoon rabies control programme was modelled as
reductions in future costs. For example, future efficiency
gains could be produced by new ORV baits with higher
efficacy potentially reducing the number of baits distrib-
uted on the landscape leading to an overall reduction in
costs. The parameter values of the disease spread model
were not modified to reflect possible impact of the choice
of any of the three cost scenarios. This analysis deter-
mined the overall impact of reduced budgetary expendi-
tures on the breakeven year and on programme
efficiency. Contingency actions costs or costs associated
with a disruption (e.g. flare-up of rabies in a previously
controlled area) in the control programme were not
included in this analysis. Contingency actions are not
always necessary for programme success, and future anal-
ysis could include an examination of the impact of con-
tingency actions.
Results
Total benefits accruing to the raccoon rabies control pro-
gramme were the calculated savings owing to the pro-
gramme (the projected prevented number of PEPs, ATs
and INVTs and their cost to society) over the study per-
iod 2007–2018 (Tables 2 and 3). When the estimated
benefits were compared to the costs of the raccoon rabies
control programme, the potential ratios of benefits to
Table 1. Estimated Quebec raccoon rabies control programme cost
projections for scenarios 1, 2, and 3 (costs maintained versus future
efficiency gains)*
Year Scenario 1 Scenario 2 Scenario 3
2006 $1 383 008 $1 383 008 $1 383 008
2007 $4 474 350 $4 474 350 $4 474 350
2008 $4 452 600 $4 452 600 $4 452 600
2009 $3 833 000 $3 833 000 $3 833 000
2010 $3 833 000 $3 833 000 $3 833 000
2011 $3 833 000 $3 833 000 $2 299 800
2012 $3 833 000 $3 833 000 $2 299 800
2013 $3 833 000 $1 916 500 $2 299 800
2014 $3 833 000 $1 916 500 $2 299 800
2015 $3 833 000 $1 916 500 $1 533 200
2016 $3 833 000 $1 916 500 $1 533 200
2017 $3 833 000 $1 916 500 $1 533 200
2018 $3 833 000 $1 916 500 $1 533 200
Total $48 639 958 $37 140 958 $33 307 958
*All numbers in 2008 CAD.
Bioeconomic Modeling of Raccoon Rabies Spread Management S. Shwiff et al.
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costs were determined. In this analysis, total (cumulative)
programmatic benefit-cost ratios ranged from 0.96 to
1.55 (Tables 4 and 5). This indicates every dollar spent
on the raccoon rabies control programme saves between
$.96 and $1.55 in prevented costs to society.
Level 1
This level of benefits omitted any savings derived from
indirect costs associated with PEP (Table 2). Future
reductions in programme costs matter in terms of overall
programme economic efficiency. Under scenario 1, the
overall programme benefits are approximately equal to
costs with a ratio of benefits to costs of .98, mainly owing
to the static nature of long-term programme costs. For
scenarios 2 and 3, overall benefits exceed the costs when
estimated over the life of the programme.
Level 2
Inclusion of the indirect cost savings associated with PEP
more accurately reflects the cost burden associated with
human exposure to rabies (Table 3). Under all costs sce-
narios, overall programme benefits exceed costs. The
combination of indirect costs associated with PEP and
long-term programme cost savings provides the best
potential returns associated with the programme, with
benefits ($6 044 668) approximately four times greater
than costs ($1 533 200).
Discussion
Successful elimination of the spread of an expensive and
deadly disease like raccoon variant rabies often leaves
economists, public health organizations and legislators
Table 2. Estimated level 1 number and value of prevented raccoon rabies impacts: post-exposure prophylaxis (PEP), animal testing (AT) and
human exposure investigation (INVT) from 2007 to 2018*
Year PEP PEP Savings AT AT Savings INVT INVT Savings Total/year
2007 396 $579 849 1736 $467 057 3450 $428 925 $1 475 831
2008 391 $572 243 1713 $460 930 3405 $423 298 $1 456 471
2009 1324 $1 938 500 5805 $1 561 423 11 535 $1 433 943 $4 933 866
2010 1394 $2 041 066 6112 $1 644 038 12 145 $1 509 813 $5 194 917
2011 1409 $2 062 762 6177 $1 661 514 12 274 $1 525 862 $5 250 137
2012 1510 $2 210 332 6619 $1 780 378 13 153 $1 635 022 $5 625 733
2013 1463 $2 141 310 6412 $1 724 782 12 742 $1 583 965 $5 450 056
2014 1431 $2 095 332 6274 $1 687 748 12 468 $1 549 954 $5 333 034
2015 1431 $2 095 332 6274 $1 687 748 12 468 $1 549 954 $5 333 034
2016 1318 $1 929 590 5778 $1 554 246 11 482 $1 427 352 $4 911 189
2017 257 $376 431 1127 $303 208 2240 $278 453 $958 092
2018 210 $307 742 921 $247 880 1831 $227 642 $783 265
Total 12 537 $18 350 490 54 948 $14 780 952 109 194 $13 574 183 $46 705 625
*All numbers in 2008 CAD.
Table 3. Estimated level 2 number and value of prevented raccoon rabies impacts: prevented post-exposure prophylaxis (PEP), animal testing (AT)
and human exposure investigation (INVT) from 2007 to 2018*
Year PEP PEP Savings AT AT Savings INVT INVT Savings Total/year
2007 396 $771 199 1736 $467 057 3450 $428 925 $1 672 764
2008 391 $761 083 1713 $460 930 3405 $423 298 $1 650 820
2009 1324 $2 578 205 5805 $1 561 423 11 535 $1 433 943 $5 592 235
2010 1394 $2 714 618 6112 $1 644 038 12 145 $1 509 813 $5 888 120
2011 1409 $2 743 474 6177 $1 661 514 12 274 $1 525 862 $5 950 709
2012 1510 $2 939 742 6619 $1 780 378 13 153 $1 635 022 $6 376 424
2013 1463 $2 847 942 6412 $1 724 782 12 742 $1 583 965 $6 177 305
2014 1431 $2 786 792 6274 $1 687 748 12 468 $1 549 954 $6 044 668
2015 1431 $2 786 792 6274 $1 687 748 12 468 $1 549 954 $6 044 668
2016 1318 $2 566 355 5778 $1 554 246 11 482 $1 427 352 $5 566 532
2017 257 $500 654 1127 $303 208 2240 $278 453 $1 085 939
2018 210 $409 297 921 $247 880 1831 $227 642 $887 783
Total 12 537 $24 406 152 54 948 $14 780 952 109 194 $13 574 183 $52 937 965
*All numbers in 2008 CAD.
S. Shwiff et al. Bioeconomic Modeling of Raccoon Rabies Spread Management
ª Published 2012. This article is a US Government work and is in the public domain in the USA. 5
wondering what would have been the monetary conse-
quences if the programme had not been successful. This
study provided a methodology to estimate the economic
impact of limiting the spread of rabies, when compared
with classically used methods. One main difficulty in
bioeconomic modelling of most zoonotic diseases lies in
the accurate prediction of HPR. Previously reported
methodologies for the calculation of the HPR for rabies
either consider the entire study area at risk once the first
case has been detected (Uhaa et al., 1992; Aubert, 1999)
or consider that only a restricted part of the study area is
at risk at the detection of the first case and then expand
through the area based on arbitrary choices (Shwiff et al.,
2009) or according to the expansion of the epizootic front
at constant speed (Kemere et al., 2002; Shwiff et al.,
2008). The most significant contribution of this study
includes adding additional sophistication to the economic
analysis by enhancing the quantification of HPR based
upon the simulation of disease spread within the raccoon
population. The use of this mathematical model made it
possible to include many biological aspects neglected by
more conventional approaches (i.e. biology of the disease
vector, such as birth rate, mortality rates, movements)
and produce estimates of disease spread more specific to
the conditions in the study area. This study shows pre-
venting the entry of the disease into a highly populated
urban area such as Montreal is crucial to achieve cost effi-
ciency in a rabies control programme and should be pri-
oritized as an objective of the programme. For these
reasons, we believe this study illustrates a useful tool for
decision-making.
Another challenge of this study was determining the
hypothetical annual frequencies of public health interven-
tions (PEP, AT and INVT) that would have existed in the
absence of a raccoon rabies control programme, which
were used to calculate damages avoided in the economic
analysis. The estimated frequencies were based on informa-
tion from the raccoon rabies epizootics in New Brunswick,
New Jersey and New York. The use of these average and
adjusted frequencies reduces uncertainty of the monetary
value of damages avoided; however, inclusion of additional
information would further refine the results, thus underlin-
ing the need for more reported and published data on the
effects of rabies epizootics on public health interventions.
A range of potential programme benefits (levels 1 and 2)
were estimated to compare with three programmatic con-
trol cost scenarios. This prospective analysis of the control
programme to prevent the spread and eventual elimination
of the emerging raccoon rabies in the province of Quebec
indicated economic efficiency of the programme for a vari-
ety of modelled outcomes. Some modelled outcomes indi-
cated that efficiency is not possible given the derived
benefits and the estimated costs signalling a potentially
inefficient use of government expenditures.
This analysis estimated a range of potential future con-
trol programme costs. A static budget into the future,
while potentially realistic, does not convey the possibility
of reduced control programme expenditures owing to
either efficiency gains within the programme or contain-
ment or elimination of the raccoon rabies variant in the
province. For example, in Texas, an initial ORV pro-
gramme contained the spread of the domestic dog coy-
ote-variant rabies and an ORV zone was established at
the United States – Mexico border to prevent the reintro-
duction into Texas (Sidwa et al., 2005). Costs associated
with containing the spread of the variant in Texas were
higher than the subsequent years when costs were only
Table 4. Estimated benefit-cost ratios for level 1 benefits (PEP direct
cost savings only) and three calculated cost scenarios (costs main-
tained versus future efficiency gains), from 2007 to 2018
Year
Scenario 1 Scenario 2 Scenario 3
BCR BCR/year BCR BCR/year BCR BCR/year
2007 0.03 0.33 0.04 0.33 0.04 0.33
2008 0.06 0.33 0.08 0.33 0.09 0.33
2009 0.16 1.29 0.21 1.29 0.24 1.29
2010 0.27 1.36 0.35 1.36 0.39 1.36
2011 0.38 1.37 0.49 1.37 0.55 2.28
2012 0.49 1.47 0.64 1.47 0.72 2.45
2013 0.60 1.42 0.79 2.84 0.88 2.37
2014 0.71 1.39 0.93 2.78 1.04 2.32
2015 0.82 1.39 1.08 2.78 1.20 3.48
2016 0.92 1.28 1.21 2.56 1.35 3.20
2017 0.94 0.25 1.24 0.50 1.38 0.62
2018 0.96 0.20 1.26 0.41 1.40 0.51
Table 5. Estimated benefit-cost ratios for level 2 benefits (post-expo-
sure prophylaxis indirect cost savings included) and three calculated
cost scenarios (costs maintained versus future efficiency gains), from
2007 to 2018
Year
Scenario 1 Scenario 2 Scenario 3
BCR BCR/year BCR BCR/year BCR BCR/year
2007 0.03 0.37 0.04 0.37 0.05 0.37
2008 0.07 0.37 0.09 0.37 0.10 0.37
2009 0.18 1.45 0.24 1.45 0.27 1.45
2010 0.30 1.53 0.40 1.53 0.44 1.53
2011 0.43 1.55 0.56 1.55 0.62 2.58
2012 0.56 1.66 0.73 1.66 0.81 2.76
2013 0.68 1.61 0.89 3.21 1.00 2.68
2014 0.81 1.57 1.06 3.14 1.18 2.62
2015 0.93 1.57 1.22 3.14 1.36 3.93
2016 1.04 1.45 1.37 2.89 1.52 3.62
2017 1.07 0.28 1.40 0.56 1.56 0.71
2018 1.08 0.23 1.42 0.46 1.58 0.58
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related to maintaining the ORV zone (Shwiff et al., 2008).
It is possible that similar efficiency gains through econo-
mies of scale in the baiting programme or potential
increases in vaccine efficiency could also be realized with
the control programme. Following the completion of the
study, the inclusion of future programme efficiency gains
with the BCA has been supported. In Quebec, despite the
diminishing budget for rabies control and the size of the
baited area remaining consistent, the efficiency of baiting
techniques has been ameliorated.
In conclusion, economic efficiency is one of the many
factors that play a role in determining the utility of rabies
control programmes. This study provides an example of
how to estimate the cost efficiency of a raccoon rabies
control programme, even though many unknowns were
involved in the original decision. In this work, stochastic
elements were only included to simulate disease spread.
This analysis can be used as the foundation for several
future analyses; first, the incorporation of stochasticity
into the economic parameterizing of elements such PEP,
AT and INVT, and second, the use of economic com-
puter simulation software to model the change in eco-
nomic activity as a result of the control of raccoon rabies.
All bioeconomic modelling systems possess an inherent
variability, and the inclusion of a more comprehensive set
of stochastic components in the modelling process would
provide for probability distributions of the bioeconomic
outputs from the model instead of a limited, discrete set
of scenario results (Ludwig et al., 2009b). Future research
to model the economic impact of government spending
to prevent the spread of raccoon rabies in Quebec could
use the information provided in this analysis to inform
economic impact input–output modelling software. This
would certainly be of even greater interest for decision-
makers and stakeholders in the process of programme
implementation or continuity evaluation.
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